Clinical trial
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis…
NCT00462384 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00462384 |
|---|---|
| Title | A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease. |
| Official title | An Open-label, Multi-center Study to Demonstrate Correction of Anemia and to Assess the Maintenance of Hemoglobin Levels Using Subcutaneous Once Monthly Injections of Mircera in Pre-dialysis Patients With Chronic Kidney Disease |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Methoxy Polyethylene Glycol-epoetin Beta |
| Enrollment | 39 |
| Start date | Feb 1, 2008 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Apr 19, 2007 |
| Last update posted | Apr 1, 2016 |
| Countries | Estonia, Finland, Latvia, Norway |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: